A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)

Completed · Phase 4

Conditions studied: Asthma

In brief

This multicenter, prospective study will evaluate the baseline participant characteristics (including biomarkers) associated with a variety of individual and composite clinical outcomes in participants with moderate to severe asthma initiating treatment with omalizumab.

Key facts

Study ID

NCT01922037

Run by

Hoffmann-La Roche

People needed

806

Starts

2013-06-19

Expected to finish

2016-03-31

Last updated by the study team

2017-12-11

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants identified by the investigator as a candidate for treatment for asthma with omalizumab
• Confirmation of access to omalizumab through insurance or other source of funding

You may not qualify if…

• Enrollment in any other concurrent clinical trial or observational study
• Participants for whom omalizumab treatment is contraindicated
• Participants who had a prior allergic reaction to omalizumab or its excipients
• Participants treated with omalizumab within the previous year
• Participants who received an experimental drug as part of another study within 3 months of enrollment

Where it is running

• Achieve Clinical Research, LLC — Birmingham, Alabama, United States
• Huntsville Lung Associates PC — Huntsville, Alabama, United States
• San Tan Allergy & Asthma — Gilbert, Arizona, United States
• Dedicated Clinical Research — Goodyear, Arizona, United States
• Allergy Associates of Tucson — Tucson, Arizona, United States
• University of Arizona — Tucson, Arizona, United States
• Little Rock Allergy & Asthma; Clinical Research Center — Little Rock, Arkansas, United States
• Stuart Epstein MD - PP — Beverly Hills, California, United States
• West Coast Clinical Trials Global, LLC — Costa Mesa, California, United States
• Peninsula Allergy Associates — Daly City, California, United States
• Allianz Medical and Research Center — Fountain Valley, California, United States
• William Ebbeling MD - PP — Fresno, California, United States
• Gettysburg Medical Clinic — Fresno, California, United States
• Allergy & Asthma Inst Valley — Granada Hills, California, United States
• VA Loma Linda Healthcare System — Loma Linda, California, United States
• Allergy Asthma Care Ctr, Inc. — Los Angeles, California, United States
• Southern California Research Center — Mission Viejo, California, United States
• North Bay Allergy & Asthma; Medical Assoc — Napa, California, United States
• Choc Psf, Amc — Orange, California, United States
• Clinical Trials of Orange County — Orange, California, United States
• California Allergy & Asthma Medical Group, Inc. — Palmdale, California, United States
• Joann Blessing-Moore MD - PP — Palo Alto, California, United States
• TPMG - Rancho Cordova — Rancho Cordova, California, United States
• Redding Allergy & Asthma Care — Redding, California, United States
• Alabama Allergy & Asthma — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.